The clonal heterogeneity of colon cancer with liver metastases

[1]  P. Gibbs,et al.  Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. , 2022, The Lancet. Oncology.

[2]  Zhenglin Du,et al.  Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022 , 2021, Nucleic Acids Res..

[3]  Wenming Zhao,et al.  The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types , 2021, bioRxiv.

[4]  Shujiro Okuda,et al.  Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer , 2021, Journal of Gastroenterology.

[5]  Rang Liu,et al.  LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma , 2021, International journal of biological sciences.

[6]  M. Millward,et al.  Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy , 2020, Journal for ImmunoTherapy of Cancer.

[7]  Christopher A. Miller,et al.  The clonal evolution of metastatic colorectal cancer , 2020, Science Advances.

[8]  Z. Lu,et al.  Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer , 2019, Cell Research.

[9]  T. Chan,et al.  Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy , 2019, Nature Medicine.

[10]  Yuan Lin,et al.  Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy , 2019, Theranostics.

[11]  Yuwei Cheng,et al.  An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies. , 2019, The oncologist.

[12]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[13]  Peter J Park,et al.  Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data , 2018, Genome research.

[14]  M. Bandehpour,et al.  Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy. , 2018, Current cancer drug targets.

[15]  M. Berger,et al.  Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy , 2018, Science.

[16]  Andrea Sottoriva,et al.  Between-Region Genetic Divergence Reflects the Mode and Tempo of Tumor Evolution , 2017, Nature Genetics.

[17]  Levi Garraway,et al.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.

[18]  Eric Talevich,et al.  CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing , 2016, PLoS Comput. Biol..

[19]  M. Meyerson,et al.  DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors , 2015, BMC Cancer.

[20]  Iman Hajirasouliha,et al.  Fast and scalable inference of multi-sample cancer lineages , 2014, Genome Biology.

[21]  C. Seretis,et al.  Colorectal cancer: seed and soil hypothesis revisited. , 2014, Anticancer research.

[22]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[23]  Krishnendu Chatterjee,et al.  Evolutionary dynamics of cancer in response to targeted combination therapy , 2013, eLife.

[24]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[25]  Carlo C. Maley,et al.  Clonal evolution in cancer , 2012, Nature.

[26]  I. Fidler,et al.  The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs , 2011, International journal of cancer.

[27]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[28]  W. Grady,et al.  Genomic and epigenetic instability in colorectal cancer pathogenesis. , 2008, Gastroenterology.

[29]  Nadir Arber,et al.  The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy , 2008, Expert review of gastroenterology & hepatology.

[30]  C. Maley,et al.  Cancer as an evolutionary and ecological process , 2006, Nature Reviews Cancer.

[31]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[32]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .